Lanreotideautogel/depot may be a safe management technique for patients with metastatic intestinal and pancreatic neuroendocrine tumors, according to research presented at the 2017 Gastrointestinal Cancers Symposium.
GI & Endoscopy
A study in World Journal of Gastroenterology investigated whether offering noninvasive multitarget stool DNA tests would improve colorectal cancer screening rates.
Here are the five most read gastroenterology/endoscopy stories for Jan. 16 to Jan. 20, 2017.
Scott Arlin, MD, is a gastroenterologist at Columbus-based Ohio Gastroenterology Group.
The American Gastroenterological Association, RealCME and RMEI Medical Education completed the first phase of their continuing medical education curriculum and research initiative for community-based GI clinicians to improve care for inflammatory bowel diseases.
Advertisement
Digestive diseases cost the nation billions every year and kill hundreds of thousands of Americans, according to National Institute of Diabetes and Digestive and Kidney Diseases data.
Paramvir S. Rahal, MD, is a gastroenterologist at Bakersfield, Calif.-based Institute of Advanced Gastroenterology.
Throughout Chattanooga, Tenn., walkers and runners will take their mark to promote colon cancer awareness during the 2017 Greater Chattanooga Rump Run 5K and Fun Walk For Colon Cancer Awareness on March 11, 2017, according to TheChattanoogan.com.
Patients diagnosed with advanced gastroenteropancreatic neuroendocrine tumors often choose a combination of treatment options, according to research presented at the 2017 Gastrointestinal Cancers Symposium.
A study in Clinical Infectious Diseases investigated whether fecal transplantation is an effective treatment for recurrent Clostridium difficile infection.